21May
21May
Wasabi Raises Additional $25M in Funding, Led by Prosperity7 Ventures, and Extends Series C to $137M in Financing
Wasabi, the hot cloud storage company, today announced $25 million in additional funding led by Prosperity7 Ventures, the diversified growth fund of Aramco Ventures. Western Digital Capital, the investment arm of storage device manufacturer Western Digital, also participated in the round. This round is an extension of Wasabi’s Series C financing announced in April, expanding the total funding raised for the round to $137 million and the company’s total equity financing to $244 million. Read more >>
20May
Aramco Venture Arm Investing in U.S. Startup Wasabi
The venture capital arm of Saudi Arabia’s state-owned energy producer Aramco is investing in Boston-area cloud-storage startup Wasabi Technologies. One of Aramco’s funds, Prosperity7 Ventures, is contributing to a $25 million follow-on investment, alongside the venture capital arm of disk-drive maker Western Digital Corp., Wasabi Chief Executive Officer David Friend said exclusively in a Bloomberg Radio interview Wednesday. Read more >>
20May
Zylö and Amifar Laboratorios Forge Broad-Ranging Partnership
Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that it has entered into a broad-ranging agreement with Amifar Laboratorios Spain to supply Z-pods to further enhance Amifar’s new line of advanced cosmetics. Amifar and Zylö have initiated a product development collaboration beginning with two actives and have plans to expand the list of actives over time. Read more >>
07Apr
RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology
RevBio, Inc., announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant expected to total $2 million over two years from the National Institute on Aging, part of the National Institutes of Health. This funding will allow the company to pursue the treatment of wrist fractures with its patented bone adhesive technology known as Tetranite®. Read more >>
10Mar
RevBio Awarded Funding to Conduct an In Vivo Bone Experiment on the International Space Station
RevBio, Inc., announced that it has been awarded the opportunity to conduct an in vivo research experiment on the International Space Station U.S. National Laboratory (ISS National Lab). Read more >>
19Feb
Sealing the Deal – Using Bone Glue to Treat Pain from Wisdom-Tooth Extractions
For many teens, having one or more wisdom teeth removed is a health milestone after the first third molar teeth come in at the very back of the mouth and there isn’t enough room for them. But with this milestone also often comes another one – their first exposure to opioids. “Of about 10 million wisdom-tooth extractions done in a year, about a third come with a prescription for an opioid,” says George Kay, D.M.D., Chief Scientific Officer at the...
05Feb
RevBio Enters the Animal Health Market to Help Improve Canine Dental Care
As its first veterinary application, RevBio, Inc. announced that it has initiated a clinical study to validate the use of its innovative bone adhesive biomaterial to fill tooth extraction sockets in dogs in order to improve healing, maintain and support jaw thickness, and restore the structural stability which may help resist potential mandibular fractures. Read more >>
27Jan
‘Anti-superficial’ dating app S’More raises $2.1M
S’More, a dating app that’s focused on helping users find more meaningful relationships, announced today that it has raised $2.1 million in seed funding. Read more >>
26Jan